(NASDAQ: PACB) Pacific Biosciences Of California's forecast annual revenue growth rate of 10.41% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.64%.
Pacific Biosciences Of California's revenue in 2025 is $156,110,000.On average, 5 Wall Street analysts forecast PACB's revenue for 2025 to be $47,783,557,539, with the lowest PACB revenue forecast at $47,278,334,171, and the highest PACB revenue forecast at $48,185,453,417. On average, 5 Wall Street analysts forecast PACB's revenue for 2026 to be $55,810,962,118, with the lowest PACB revenue forecast at $55,074,453,380, and the highest PACB revenue forecast at $57,070,416,090.
In 2027, PACB is forecast to generate $68,335,215,114 in revenue, with the lowest revenue forecast at $67,424,191,051 and the highest revenue forecast at $69,205,388,774.